• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与非吸毒者相比,静脉吸毒者中新冠病毒的血清流行率。

The Seroprevalence of COVID-19 in Intravenous Drug Users in Comparison to Non-drug Users.

作者信息

Mohammadi Zahra, Eghtesad Sareh, Hashemi-Shahri Seyed Mohammad, Tabatabaei Seyed Mehdi, Sharafkhah Maryam, Poustchi Hossein

机构信息

Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.

出版信息

Middle East J Dig Dis. 2021 Jan;13(1):67-70. doi: 10.34172/mejdd.2021.206. Epub 2021 Mar 2.

DOI:10.34172/mejdd.2021.206
PMID:34712441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8531943/
Abstract

BACKGROUND COVID-19 infection has led to a worldwide pandemic, and new cases are on the rise. Intravenous drug users (IVDU) are presumably at a higher risk of being infected since they have poor personal hygiene, live in groups, and have risky behaviors. The current study aimed to evaluate the seroprevalence of COVID-19 in IVDU in comparison with non-drug users (N-DU). METHODS This cross-sectional study was conducted on 167 IVDU and 134 N-DU. A questionnaire gathering data on demographics, comorbidities, and use of personal protective equipment was administered to all participants. In addition, 5 cc of blood was taken from each individual to test for SARS-CoV-2 specific antibodies (Pishtaz Teb SARS-Cov-2 ELISA kits). RESULTS The mean age of N-DU and IVDU were 38.9 ± 12.9 and 40.38 ± 10.24 years, respectively. COVID-19 seroprevalence in IVDU was 9.7%, and 4.8% in N-DU, but this finding was not statistically significant ( = 0.096). CONCLUSION While the seroprevalence of COVID-19 was not significantly different among the two groups, IVDU should still be considered by policymakers as a high-risk group due to their lifestyle and risky behaviors. Providing personal protective equipment and other means of protection and treatment to this population can help mitigate the spread of and mortality from COVID-19.

摘要

背景

新型冠状病毒肺炎(COVID-19)感染已导致全球大流行,新病例不断增加。静脉吸毒者(IVDU)因个人卫生差、群居且存在危险行为,推测感染风险更高。本研究旨在评估与非吸毒者(N-DU)相比,IVDU中COVID-19的血清流行率。方法:对167名IVDU和134名N-DU进行了这项横断面研究。向所有参与者发放了一份收集人口统计学、合并症和个人防护装备使用情况数据的问卷。此外,从每个人身上采集5毫升血液,检测新型冠状病毒2(SARS-CoV-2)特异性抗体(Pishtaz Teb SARS-Cov-2 ELISA试剂盒)。结果:N-DU和IVDU的平均年龄分别为38.9±12.9岁和40.38±10.24岁。IVDU中COVID-19的血清流行率为9.7%,N-DU中为4.8%,但这一结果无统计学意义(P = 0.096)。结论:虽然两组中COVID-19的血清流行率无显著差异,但由于其生活方式和危险行为,政策制定者仍应将IVDU视为高危人群。为该人群提供个人防护装备以及其他防护和治疗手段有助于减轻COVID-19的传播和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d833/8531943/4b208812f105/mejdd-13-67-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d833/8531943/4b208812f105/mejdd-13-67-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d833/8531943/4b208812f105/mejdd-13-67-g001.jpg

相似文献

1
The Seroprevalence of COVID-19 in Intravenous Drug Users in Comparison to Non-drug Users.与非吸毒者相比,静脉吸毒者中新冠病毒的血清流行率。
Middle East J Dig Dis. 2021 Jan;13(1):67-70. doi: 10.34172/mejdd.2021.206. Epub 2021 Mar 2.
2
HIV infection among intravenous drug users: epidemiology and risk reduction.静脉注射吸毒者中的艾滋病毒感染:流行病学与风险降低
AIDS. 1987 Jul;1(2):67-76.
3
HIV testing, HIV infection and associated risk factors among inmates in south-eastern French prisons.法国东南部监狱囚犯中的艾滋病毒检测、艾滋病毒感染及相关风险因素
AIDS. 1994 Sep;8(9):1341-4. doi: 10.1097/00002030-199409000-00020.
4
High prevalence of hepatitis C virus infection in Belgian intravenous drug users and potential role of the "cotton-filter" in transmission: the GEMT Study.比利时静脉注射吸毒者中丙型肝炎病毒感染的高流行率及“棉花过滤”在传播中的潜在作用:GEMT研究
Acta Gastroenterol Belg. 2000 Apr-Jun;63(2):147-53.
5
Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors.伊朗伊斯法罕静脉吸毒者中的丙型肝炎:血清流行率及危险因素研究
Int J Prev Med. 2012 Mar;3(Suppl 1):S131-8.
6
Primary pyogenic infection of the spine in intravenous drug users: a prospective observational study.静脉药物使用者脊柱原发性化脓性感染:一项前瞻性观察研究。
Spine (Phila Pa 1976). 2012 Apr 15;37(8):685-92. doi: 10.1097/BRS.0b013e31823b01b8.
7
Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Health Care Workers.医护人员中SARS-CoV-2抗体的血清流行率及相关因素
J Assoc Physicians India. 2021 Aug;69(8):11-12.
8
HIV infection in European female sex workers: epidemiological link with use of petroleum-based lubricants. European Working Group on HIV Infection in Female Prostitutes.欧洲女性性工作者中的艾滋病毒感染:与使用石油基润滑剂的流行病学关联。欧洲女性妓女艾滋病毒感染问题工作组。
AIDS. 1993 Mar;7(3):401-8.
9
[Seroprevalence of viral hepatitis A in France in homosexuals and intravenous drug users].
Presse Med. 1996 Sep 7;25(25):1141-3.
10
The high level of adherence to personal protective equipment in health care workers efficiently protects them from COVID-19 infection.医护人员对个人防护设备的高度坚持使用,有效地保护他们免受 COVID-19 感染。
Work. 2021;69(4):1191-1196. doi: 10.3233/WOR-210634.

本文引用的文献

1
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.COVID-19 风险和患有物质使用障碍患者的结局:来自美国电子健康记录的分析。
Mol Psychiatry. 2021 Jan;26(1):30-39. doi: 10.1038/s41380-020-00880-7. Epub 2020 Sep 14.
2
COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper.2019冠状病毒病与物质使用障碍:全面医疗应对建议。国际成瘾医学学会实践与政策兴趣小组立场文件
Basic Clin Neurosci. 2020 Mar-Apr;11(2):133-150. doi: 10.32598/bcn.11.covid19.1. Epub 2020 Apr 12.
3
Influencing Factors of Understanding COVID-19 Risks and Coping Behaviors among the Elderly Population.
影响老年人理解 COVID-19 风险和应对行为的因素。
Int J Environ Res Public Health. 2020 Aug 13;17(16):5889. doi: 10.3390/ijerph17165889.
4
Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks.COVID-19 对注射毒品者带来的挑战及其他疫情暴发带来的经验教训。
J Int AIDS Soc. 2020 Jul;23(7):e25583. doi: 10.1002/jia2.25583.
5
COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.新型冠状病毒肺炎与物质使用障碍患者:不公平现象与缓解策略。
Subst Abus. 2020;41(3):286-291. doi: 10.1080/08897077.2020.1784363.
6
Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.Covid-19 与心血管风险:对 SARS-CoV-2 的易感性、Covid-19 的严重程度和预后以及肾素-血管紧张素-醛固酮系统的阻断。基于证据的观点。
Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1227-1235. doi: 10.1016/j.numecd.2020.05.013. Epub 2020 May 29.
7
Prevalence of drug use, alcohol consumption, cigarette smoking and measure of socioeconomic-related inequalities of drug use among Iranian people: findings from a national survey.伊朗人群中药物使用、酒精消费、吸烟的流行情况以及与药物使用相关的社会经济不平等衡量标准:一项全国性调查的结果。
Subst Abuse Treat Prev Policy. 2020 Jun 5;15(1):39. doi: 10.1186/s13011-020-00279-1.
8
COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System.新型冠状病毒肺炎和严重急性呼吸综合征冠状病毒 2 感染:发病机制及对神经系统的临床影响。
World Neurosurg. 2020 Aug;140:49-53. doi: 10.1016/j.wneu.2020.05.193. Epub 2020 May 28.
9
Diabetes and metabolic syndrome as risk factors for COVID-19.糖尿病和代谢综合征作为新冠病毒疾病的风险因素。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):671-677. doi: 10.1016/j.dsx.2020.05.013. Epub 2020 May 8.
10
The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.新型冠状病毒肺炎大流行及其对物质使用的影响:对预防和治疗的启示。
Psychiatry Res. 2020 Jul;289:113096. doi: 10.1016/j.psychres.2020.113096. Epub 2020 May 13.